Trial · NCT01254045
Participant flow54
How many started, completed or left each group, period by period.
1 to 20 of 54
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| First/Baseline (1 Day at Week 1 ) | STARTED | Placebo 48IU, Oxytocin 24IU/Placebo 24IU, Oxytocin 48IU | 2 | |
| First/Baseline (1 Day at Week 1 ) | STARTED | Oxytocin 24IU/Placebo 24IU, Placebo 48IU, Oxytocin 48IU | 2 | |
| First/Baseline (1 Day at Week 1 ) | STARTED | Oxytocin 48IU, Oxytocin 24IU/Placebo 24IU, Placebo 48IU | 2 | |
| First/Baseline (1 Day at Week 1 ) | STARTED | Oxytocin 24IU/Placebo 24IU, Oxytocin 48IU, Placebo 48IU | 1 | |
| First/Baseline (1 Day at Week 1 ) | STARTED | Oxytocin 48IU, Placebo 48IU, Oxytocin 24IU/Placebo 24IU | 1 | |
| First/Baseline (1 Day at Week 1 ) | STARTED | Placebo 48IU, Oxytocin 48IU, Oxytocin 24IU/Placebo 24IU | 1 | |
| First/Baseline (1 Day at Week 1 ) | COMPLETED | Placebo 48IU, Oxytocin 24IU/Placebo 24IU, Oxytocin 48IU | 1 | |
| First/Baseline (1 Day at Week 1 ) | COMPLETED | Oxytocin 24IU/Placebo 24IU, Placebo 48IU, Oxytocin 48IU | 2 | |
| First/Baseline (1 Day at Week 1 ) | COMPLETED | Oxytocin 48IU, Oxytocin 24IU/Placebo 24IU, Placebo 48IU | 2 | |
| First/Baseline (1 Day at Week 1 ) | COMPLETED | Oxytocin 24IU/Placebo 24IU, Oxytocin 48IU, Placebo 48IU | 1 | |
| First/Baseline (1 Day at Week 1 ) | COMPLETED | Oxytocin 48IU, Placebo 48IU, Oxytocin 24IU/Placebo 24IU | 1 | |
| First/Baseline (1 Day at Week 1 ) | COMPLETED | Placebo 48IU, Oxytocin 48IU, Oxytocin 24IU/Placebo 24IU | 1 | |
| First/Baseline (1 Day at Week 1 ) | NOT COMPLETED | Placebo 48IU, Oxytocin 24IU/Placebo 24IU, Oxytocin 48IU | 1 | |
| First/Baseline (1 Day at Week 1 ) | NOT COMPLETED | Oxytocin 24IU/Placebo 24IU, Placebo 48IU, Oxytocin 48IU | 0 | |
| First/Baseline (1 Day at Week 1 ) | NOT COMPLETED | Oxytocin 48IU, Oxytocin 24IU/Placebo 24IU, Placebo 48IU | 0 | |
| First/Baseline (1 Day at Week 1 ) | NOT COMPLETED | Oxytocin 24IU/Placebo 24IU, Oxytocin 48IU, Placebo 48IU | 0 | |
| First/Baseline (1 Day at Week 1 ) | NOT COMPLETED | Oxytocin 48IU, Placebo 48IU, Oxytocin 24IU/Placebo 24IU | 0 | |
| First/Baseline (1 Day at Week 1 ) | NOT COMPLETED | Placebo 48IU, Oxytocin 48IU, Oxytocin 24IU/Placebo 24IU | 0 | |
| Second/Time 2 (1 Day at Week 2) | STARTED | Placebo 48IU, Oxytocin 24IU/Placebo 24IU, Oxytocin 48IU | 1 | |
| Second/Time 2 (1 Day at Week 2) | STARTED | Oxytocin 24IU/Placebo 24IU, Placebo 48IU, Oxytocin 48IU | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01254045/flow